SRRK
Scholar Rock Holding Corporation · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -9.5% ·
aandelenstroom +2.8% ·
netto nieuwe posities -15.8%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 5.86K | $247,641 | n/a | n/a |
| Q2 2026 | 105 | +5 | 87.18M | $4.79B | +10 | −4 |
| Q1 2026 | 102 | +4 | 76.34M | $3.75B | +8 | −5 |
| Q4 2025 | 97 | -1 | 72.93M | $3.21B | +2 | −2 |
| Q3 2025 | 19 | -2 | 52.36M | $1.95B | n/a | −3 |
| Q2 2025 | 19 | +1 | 48.51M | $1.72B | +1 | n/a |
| Q1 2025 | 15 | 0 | 24.83M | $798.16M | n/a | n/a |
| Q4 2024 | 15 | +1 | 26.21M | $1.13B | +2 | −1 |
| Q3 2024 | 13 | 0 | 15.70M | $125.78M | +1 | −1 |
| Q2 2024 | 13 | n/a | 12.73M | $106.08M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 14.01M | +1.3% | $521.81M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 2 | T. Rowe Price ✦ | 6.88M | -21.4% | $256.33M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 3 | BlackRock ✦ (passief) | 6.76M | +1.0% | $251.75M | 0.0% | ▲ Add | 2 | SEC ↗ ×15 |
| 4 | The Vanguard Group ✦ (passief) | 4.91M | +1.1% | $183.03M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 5 | Wellington Management ✦ | 4.55M | +124.5% | $169.29M | 0.0% | ▲ Add | 6 | SEC ↗ ×8 |
| 6 | State Street Global Advisors ✦ (passief) | 3.76M | +22.4% | $140.14M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 1.95M | +3.6% | $72.81M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Adage Capital Partners ✦ | 1.95M | +60.6% | $72.69M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 1.56M | n/a | $58.21M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | JPMorgan Chase ✦ | 1.43M | n/a | $53.18M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 11 | Capital World Investors ✦ | 1.13M | 0.0% | $42.03M | 0.0% | Held | 4 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 1.01M | +660.7% | $37.49M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Marshall Wace ✦ | 973.91K | -40.6% | $36.27M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Morgan Stanley ✦ | 604.00K | n/a | $22.49M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 15 | Fisher Asset Management ✦ | 533.18K | +29.3% | $19.86M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 159.07K | -29.6% | $5.92M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 134.61K | -86.2% | $5.01M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | AQR Capital Management ✦ | 21.18K | -9.9% | $788,594 | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 19 | D. E. Shaw & Co. ✦ | 18.49K | -86.4% | $688,568 | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $41.63M | was 0.0% |
| Renaissance Technologies | $10.31M | was 0.0% |
| Millennium Management | $330,044 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 274 houders, 132.63M aandelen, $6.20B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.